Press Releases

The Mobile Health/Central Lab Interface, an opportunity for DCT efficiency

How streamlining relations between central labs and mobile health providers can get the most from hybrid and decentralised clinical trials

Bracknell, UK, 1 December 2022 - As the conversation around hybrid and decentralised clinical trials (DCT) moves from why to how, sponsors are increasingly seeking the best ways to embed the new model into their routine workflows.

As part of the Decentralized Trials and Research Alliance’s (DTRA) TGIF-DCT podcast series, global MedTech and patient servicing provider mdgroup will join forces with global clinical trial laboratory Q² Solutions to explain how tearing down barriers between the various vendors and service providers involved in such studies is a simple yet effective starting point. Hosted by DTRA founder Craig Lipset, mdgroup’s Director of Decentralised Clinical Solutions, Tom Brazier, will present with Q² Solutions’ Decentralised Trial Solutions Director, John Corcoran, and Manager, Stephanie Larimer.

“From sponsors to CROs and vendors, we all need to think about how to streamline the logistics of DCTs, which tend to be conducted using a patchwork of different service providers and vendors – including mobile health providers, who collect the clinical samples, and central laboratories, who analyse them,” Tom Brazier explains.

“Despite each of these service providers being dependent on the other to do their job, there is often no direct line of contact between the two. Instead, the shared client becomes the key liaison for both, impairing effective communication, draining clinical trial efficiency, and placing additional burden on the sponsor.”

The group will consider how the absence of communication between central laboratories and mobile health providers can contribute to inefficiencies, lead to duplicated efforts, and put data quality at risk. By opening lines of communication between these two parties, the discussion will illustrate how critical areas such as study set up and sample kit logistics can be streamlined, while protecting data quality.

This event will take place on 9 December, 12-1pm, EST. This podcast discussion forms part of a series of Clubhouse events, organised by the DTRA, of which mdgroup is a founding member, aimed at providing all stakeholders with an informal space to share DCT experiences and best practice.

TGIF-DCT meets every Friday 12-1pm EST for an informal space to share experiences in #decentralizedtrials on Clubhouse. To listen and for more information on TGIF-DCT: The Decentralized Trials Club, visit https://www.linkedin.com/events/tgif-dct-labs-specimensanddecen6983621269157986304/about/ or find Clubhouse to download the app on your device. 

-END-

About mdgroup

mdgroup are on a mission to deliver remarkable technologies and experiences for patients taking part in site-based and decentralised clinical trials. They support all sizes of pharma and biotech to attract, engage, maintain and support patient participation in healthcare research around the world, all underpinned by our latest innovations in healthcare technologies. Let’s make your next study remarkable. Contact us now to discuss how. Find out more at mdgroup.com

About Q² Solutions

Q² Solutions is a leading global clinical trial laboratory services organization that provides comprehensive testing, project management, supply chain, biorepository, biospecimen, and consent tracking solutions. Leveraging our next generation technologies, we deliver agile and precise services designed to meet the diverse needs of our clients. We provide scientific expertise and innovative solutions for ADME, bioanalytical, genomics, vaccines, and central laboratory services, including flow cytometry, anatomic pathology, immunoassay, molecular, companion diagnostics and translational science, with meticulous regional and global clinical trial implementation support and high-quality data delivery. At Q² Solutions, our work is rooted in research, grounded in collaboration, and guided by our passion to turn the hope of patients and caregivers around the world into the help they need. To learn more, visit q2labsolutions

Media Contact 

Amanda Leweson - Discovery PR, on behalf of mdgroup 

Email: amanda@discovery-pr.com    

Mobile: + 44 (0) 7852 153 791    Office:   +44 (0) 1606 889 194